ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

SONN Company Profile and Key Details

NASDAQ : SONN

Sonnet BioTherapeutics Holdings, Inc.

$1.51

-0.04-2.58%

At Close 4:00 PM

72.51

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

SONN Stock Price Chart

Stock Price Today

Sonnet BioTherapeutics Holdings, Inc. (SONN) stock declined over -2.58%, trading at $1.51 on NASDAQ, down from the previous close of $1.55. The stock opened at $1.52, fluctuating between $1.50 and $1.55 in the recent session.

Stock Snapshot

1.55

Prev. Close

1.52

Open

4.63M

Market Cap

3.07M

Number of Shares

1.5

Day Low

1.55

Day High

-0.14

P/E Ratio

98.76%

Free Float in %

-10.45

EPS (TTM)

0.68

Book Value

-4.99

Cash Flow per Share

26.2K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 03, 2025	1.52	1.55	1.50	1.51	25.64K
Feb 28, 2025	1.51	1.54	1.48	1.54	29.13K
Feb 27, 2025	1.50	1.55	1.50	1.54	26.86K
Feb 26, 2025	1.51	1.57	1.46	1.52	81.49K
Feb 25, 2025	1.51	1.53	1.44	1.50	24.92K
Feb 24, 2025	1.41	1.55	1.39	1.51	115.9K
Feb 21, 2025	1.44	1.46	1.38	1.44	67.9K
Feb 20, 2025	1.50	1.50	1.41	1.43	54.12K
Feb 19, 2025	1.50	1.53	1.38	1.50	422.25K
Feb 18, 2025	1.59	1.59	1.50	1.53	39.59K
Feb 14, 2025	1.57	1.60	1.54	1.59	47.53K
Feb 13, 2025	1.51	1.55	1.51	1.54	31.28K
Feb 12, 2025	1.57	1.60	1.50	1.56	69.2K
Feb 11, 2025	1.58	1.64	1.55	1.57	101.92K
Feb 10, 2025	1.62	1.66	1.55	1.59	43.56K
Feb 07, 2025	1.58	1.62	1.55	1.59	47.52K
Feb 06, 2025	1.65	1.69	1.61	1.62	32.31K
Feb 05, 2025	1.60	1.67	1.57	1.64	49.5K
Feb 04, 2025	1.57	1.65	1.55	1.62	43.03K
Feb 03, 2025	1.60	1.64	1.53	1.59	50.33K

Contact Details

Princeton, NJ 08540

United States

Website: https://www.sonnetbio.comContact: 609 375 2227

About Company

Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy. It has a license agreement with New Life Therapeutics PTE, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin 6. Sonnet BioTherapeutics Holdings, Inc. is based in Princeton, New Jersey.

Frequently Asked Questions

What is the current Sonnet BioTherapeutics Holdings, Inc. (SONN) stock price?

Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) stock price is $1.51 in the last trading session. During the trading session, SONN stock reached the peak price of $1.55 while $1.50 was the lowest point it dropped to. The percentage change in SONN stock occurred in the recent session was -2.58% while the dollar amount for the price change in SONN stock was -$0.04.

SONN's industry and sector of operation?

The NASDAQ listed SONN is part of Biotechnology industry that operates in the broader Healthcare sector. Sonnet BioTherapeutics Holdings, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SONN?

Mr. Jay Cross
Chief Financial Officer
Mr. Donald J. Griffith CPA, CPA
Controller & Director
Dr. Pankaj Mohan Ph.D.
Founder, Chairman, Chief Executive Officer & Pres
Ms. Susan Dexter
Chief Technical Officer
Mr. Manuel Dafonseca
Head of Clinical Operations
Dr. Richard T. Kenney FACP, M.D.
Chief Medical Officer
Dr. John K. Cini Ph.D.
Chief Scientific Officer & Co-Founder
Mr. Donald J. Griffith C.P.A., CPA
Controller & Director

How SONN did perform over past 52-week?

SONN's closing price is 9.42% higher than its 52-week low of $1.38 where as its distance from 52-week high of $18.72 is -91.93%.

How many employees does SONN have?

Number of SONN employees currently stands at 13.

Link for SONN official website?

Official Website of SONN is: https://www.sonnetbio.com

How do I contact SONN?

SONN could be contacted at phone 609 375 2227 and can also be accessed through its website. SONN operates from 100 Overlook Center, Princeton, NJ 08540, United States.

How many shares of SONN are traded daily?

SONN stock volume for the day was 26.2K shares. The average number of SONN shares traded daily for last 3 months was 1.09M.

What is the market cap of SONN currently?

The market value of SONN currently stands at $4.63M with its latest stock price at $1.51 and 3.07M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	13
Beta	1.03
Sales or Revenue	$18.63K
5Y Sales Change%	-1%
Fiscal Year Ends	September
Sector	Healthcare
Industry	Biotechnology